BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/6/2017 8:30:21 PM | Browse: 906 | Download: 1125
Publication Name World Journal of Gastroenterology
Manuscript ID 29107
Country/Territory Lebanon
Received
2016-07-29 09:53
Peer-Review Started
2016-08-02 20:04
To Make the First Decision
2016-09-20 08:36
Return for Revision
2017-03-09 19:30
Revised
Second Decision
2017-03-24 12:19
Accepted by Journal Editor-in-Chief
2017-03-25 18:25
Accepted by Company Editor-in-Chief
2017-03-31 07:47
Articles in Press
2017-03-31 07:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-04-21 11:22
Publish the Manuscript Online
2017-05-06 20:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality
Manuscript Source Invited Manuscript
All Author List Hampig Raphael Kourie, Samer Tabchi and Marwan Ghosn
Funding Agency and Grant Number
Corresponding Author Marwan Ghosn, MD, Department of Oncology, Faculty of Medicine, Saint Joseph University, Alfred Naccache, Beirut 166830, Lebanon. marwanghosnmd@yahoo.com
Key Words Immunotherapies; Cancers; Digestive; Checkpoint inhibitors; Gastrointestinal
Core Tip Immune checkpoint inhibitors represent new promising anti-cancer therapies, rapidly approved in different malignancies and settings. We aimed in this editorial to report all the ongoing and published trials evaluating these agents in gastro-intestinal malignancies, to focus on the past expectations and the reality of the results and finally, to discuss the future perspectives of these agents in this field.
Publish Date 2017-05-06 20:30
Citation Kourie HR, Tabchi S, Ghosn M. Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality. World J Gastroenterol 2017; 23(17): 3017-3021
URL http://www.wjgnet.com/1007-9327/full/v23/i17/3017.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i17.3017
Full Article (PDF) WJG-23-3017.pdf
Full Article (Word) WJG-23-3017.doc
Manuscript File 29107-Review.docx
Answering Reviewers 29107-Answering reviewers.pdf
Audio Core Tip 29107-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 29107-Conflict-of-interest statement.pdf
Copyright License Agreement 29107-Copyright assignment.pdf
Peer-review Report 29107-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 29107-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 29107-Scientific misconduct check.pdf
Scientific Editor Work List 29107-Scientific editor work list.pdf